Why is the CSL share price on the slide today?

Shares in the ASX healthcare giant are holding their own on Tuesday.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The ASX 200 is in the green so far this Tuesday
  • Not so the CSL share price although, curiously, it's holding up rather well
  • That's despite CSL shares trading ex-dividend today

It's been a wavering start to the trading day for the S&P/ASX 200 Index (ASX: XJO) so far this Tuesday. At the time of writing, the ASX 200 has gained just 0.09% and is back below 6,860 points. But it's still ahead of the CSL Limited (ASX: CSL) share price.

CSL shares are down 0.1% at the time of writing. The ASX 200 healthcare giant closed at $294.80 a share yesterday. It opened at $294.42 this morning and is now trading at $294.50 at the time of writing.

This doesn't exactly appear to be a strong session for CSL shares, given the ASX 200 is slightly outperforming these gains so far. But it is if we factor in what has just happened to the CSL share price. The company has just traded ex-dividend today for the upcoming final dividend payment for FY22.

When CSL revealed its full-year earnings report for FY22 last month, it declared a final dividend of US$1.18 per share. That translates to $1.68 per share, partially franked at 10%.

As we discussed yesterday, this was flat in US dollar terms on last year's final dividend. But thanks to favourable currency exchange rates, ASX investors will enjoy a 5.6% boost from what they received last year.

The dividend is scheduled to be paid out next month on 5 October, so investors will have to wait until then to see the cash.

A scientist examining test results.

Image source: Getty Images

CSL share price rises, despite ex-dividend date

But CSL shares traded ex-dividend for this upcoming final payment today. That means that any new investors in CSL from today are not eligible to receive this dividend.

Normally, when a company trades ex-dividend, we see a corresponding drop in the company's share price. This reflects the reality that CSL shares are less valuable, thanks to the fact that the dividend is no longer available for new investors.

Today, we have seen no such obvious drop. That means that CSL is having a fairly strong day – if it weren't for the ex-dividend date, the company would probably be enjoying gains.

So arguably, this is a very happy day for CSL investors.

At the current CSL share price, this ASX 200 healthcare share has a dividend yield of 1.02%.

Motley Fool contributor Sebastian Bowen has positions in CSL Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Lab worker puts hands in the air and dances around.
Healthcare Shares

CSL shares look primed to take off — Here's why

Business remains robust and brokers see ASX stock soaring up to 100%.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

ASX 300 healthcare stock outperforming today on 'strategic' leadership news

The ASX healthcare stock announced the outcome of its CEO recruitment drive this morning.

Read more »

Cropped shot of a young female scientist working on her computer in the laboratory.
Healthcare Shares

Could Telix shares be a millionaire-maker stock?

Telix looks a compelling growth story, with brokers eyeing more than 150% upside.

Read more »

A child covering his eyes hiding from a toy bear.
Healthcare Shares

Down 20% in 2026, is now the time to buy CSL shares?

CSL shares hit a new multi-year low as the 2026 decline deepens.

Read more »

Scientists in white coats look disappointed.
Healthcare Shares

Down 87% since Thursday, why is this ASX 300 healthcare stock sliding again today?

The ASX healthcare share has plunged more than 87% in five trading days.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which ASX biotech's shares have jumped more than 10% on positive clinical trial news?

A potential cancer treatment is progressing.

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

3 ASX healthcare stocks tipped to soar over 100% higher this year

These ASX shares are on my radar this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »